Evidence map›Paper›PMID 42812282›Full record

SynthesisFrontiers in immunology2026

A systematic review and meta-analysis reveals enrichment of pro-inflammatory and bacterial immunity-modulating taxa in oral squamous cell carcinoma.

Akanksha Vishwakarma, Ayurshi Patil, Diksha Saini, Akshay Shankar, Satyendra Kumar Shukla, Keerti Kushwaha, Manupal Choudhary, Manu Bhardwaj, Vandna Gupta, Chander Prakash Yadav and 1 more

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Akanksha Vishwakarma *Division of Molecular Biology, Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research, Noida, India.
Ayurshi Patil *Division of Molecular Biology, Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research, Noida, India.
Diksha SainiDivision of Molecular Biology, Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research, Noida, India.
Akshay ShankarDivision of Molecular Biology, Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research, Noida, India.
Satyendra Kumar ShuklaDivision of Molecular Biology, Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research, Noida, India.
Keerti KushwahaDepartment of Microbiology, Chaudhary Charan Singh University, Meerut, India.
Manupal ChoudharyIndian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research (NICPR), IT-Cell, Noida, India.
Manu BhardwajIndian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research (NICPR), IT-Cell, Noida, India.
Vandna GuptaDepartment of Microbiology, Chaudhary Charan Singh University, Meerut, India.
Chander Prakash YadavDivision of Epidemiology and Biostatistics, Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research (NICPR), Noida, India.
Pramod KumarDivision of Molecular Biology, Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research, Noida, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Oral squamous cell carcinoma (OSCC) is a major concern due to high recurrence, therapeutic resistance, and mortality. Increasing evidence indicates that oral microbiome dysbiosis contributes to OSCC development, yet comprehensive multi-cohort evaluations are limited. A systematic review and meta-analysis of the oral microbiome was conducted to identify conserved taxa in patients with OSCC. Methods: A systematic review and meta-analysis was conducted according to PRISMA guidelines, using data from PubMed, Embase, Web of Science, and Google Scholar. Raw 16S rDNA sequences were processed in QIIME 2 (v2024.10) for quality control, taxonomic classification, and diversity analysis. Linear Discriminant Analysis Effect Size (LEfSe) analyses and machine learning were used for the identification of conserved taxa. Results: Significant microbial shifts were observed between OSCC and healthy groups. OSCC samples showed enrichment of taxa, which further identified as conserved taxa such as Conclusion: Overall, this study demonstrates the enrichment of microbial taxa associated with chronic inflammation and carcinogenesis, along with a depletion of protective commensal microbes in patients with OSCC. These findings highlight distinct taxonomic and functional microbiome signatures associated with OSCC and emphasize the influence of sample type and geography on oral microbial composition. The enrichment of predicted inflammatory genes, transport-associated genes, and bacterial immune-related genes suggests the potential contribution of microbial communities to chronic inflammation and tumor progression.

Indexed as

BacteriaCarcinoma, Squamous CellMicrobiotaMouth NeoplasmsDysbiosisHumansconserved taxageographyNGSoral microbiomeOSCC

Identifiers

PMID42812282
PMCPMC13619387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.